Disease, Microbiology, Biotechnology, Epidemiology, Infectious disease, Medicine

STAT+ Conversations: A conversation with vaccine expert Paul Offit

On Jan 26, 2021
@matthewherper shared
RT @statnews: IN ONE HOUR @matthewherper leads our next STAT Plus Conversation: with vaccine expert Paul Offit. Be part of the conversation here: https://t.co/zYrMezluwQ Watch the live stream here: https://t.co/8WY36qR1K9
Open

STAT's Matthew Herper sits down with vaccine expert Paul Offit to discuss the ongoing Covid-19 vaccine rollout.

www.statnews.com
On Jan 26, 2021
@matthewherper shared
RT @statnews: IN ONE HOUR @matthewherper leads our next STAT Plus Conversation: with vaccine expert Paul Offit. Be part of the conversation here: https://t.co/zYrMezluwQ Watch the live stream here: https://t.co/8WY36qR1K9
Open

STAT+ Conversations: A conversation with vaccine expert Paul Offit

STAT+ Conversations: A conversation with vaccine expert Paul Offit

STAT's Matthew Herper sits down with vaccine expert Paul Offit to discuss the ongoing Covid-19 vaccine rollout.

COVID-19 vaccine trial by Moderna shows positive early results

COVID-19 vaccine trial by Moderna shows positive early results

(Xinhua) "We are investing to scale up manufacturing so we can maximize the number of doses we can produce to help protect as many people as we can from SARS-CoV-2." WASHINGTON, May 18 ...

BIOEquality, data sharing and deals: a BioCentury podcast

BIOEquality, data sharing and deals: a BioCentury podcast

BIO is calling on biopharmaceutical companies to put their pledges on social justice into practice as the trade group launches an initiative that aims to diversify the biotech workforce and ...

4 takeaways from FDA's Covid-19 vaccine meeting

4 takeaways from FDA's Covid-19 vaccine meeting

While there is no specific vaccine on the table yet, the committee is hearing from federal agencies and vaccine makers about their efforts to prove a shot is both safe and effective.

As a new Covid-19 treatment arrives, hospitals scramble to solve logistical and ethical challenges

As a new Covid-19 treatment arrives, hospitals scramble to solve logistical and ethical challenges

Hospitals need to find space and staff to administer the drug at a time when there’s hardly enough of either to treat those who are sick.

Coming soon: A breathalyzer to detect malaria?

Coming soon: A breathalyzer to detect malaria?

A Washington University researcher has pinpointed six biomarkers that could lead to a simple breathalyzer test for malaria.

Data, data and more data will make a coronavirus vaccine safe, USA TODAY's vaccine panel says

Data, data and more data will make a coronavirus vaccine safe, USA TODAY's vaccine panel says

USA TODAY's expert panel sees steady progress toward a safe and effective COVID vaccine, urge public's patience as trials proceed and data comes in.

American Doctors Are Treating a Coronavirus Patient With a Robot

American Doctors Are Treating a Coronavirus Patient With a Robot

The goal is to nip an American outbreak in the bud.

Responding to COVID-19: A Science-Based Approach

Responding to COVID-19: A Science-Based Approach

Brought to you by the American Public Health Association and the National Academy of Medicine, this webinar series will explore the state of the science surrounding the current outbreak of ...

WuXi Biologics Enables Development of Multiple Neutralizing Antibodies for Novel Coronavirus

WuXi Biologics Enables Development of Multiple Neutralizing Antibodies for Novel Coronavirus

/PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for...

DEINOVE to collaborate with CALIBR to explore broadly the anti-infectious potentials of its bacterial collection

DEINOVE to collaborate with CALIBR to explore broadly the anti-infectious potentials of its bacterial collection

CALIBR is a division of the Scripps Research, a California non-profit corporation, dedicated to finding new treatments addre

Director, Integrated Research Facility

Director, Integrated Research Facility

Division of Clinical Research POC: [email protected] Open: February 18-27, 2019

Combating infectious diseases with next-generation sequencing

Combating infectious diseases with next-generation sequencing

Infectious disease physician and clinical microbiologist Charles Chiu is the director of the Abbott Viral Diagnostics and Discovery Center at the University of California, San Francisco. ...

COVID-19 & the Latinx Community

COVID-19 & the Latinx Community

Through this forum, Hispanic scientists and doctors from Yale University will share their roles investigating the new coronavirus and treating patients with the COVID-19 disease and will ...

BIO Annual Meeting Goes Digital with Focus on COVID-19

BIO Annual Meeting Goes Digital with Focus on COVID-19

This year’s event, which kicks off June 8, will have a different look as an entirely digital conference.